Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BTLA antibody (Biotin)

The Rat Monoclonal anti-BTLA antibody has been validated for FACS. It is suitable to detect BTLA in samples from Mouse.
Catalog No. ABIN7456630

Quick Overview for BTLA antibody (Biotin) (ABIN7456630)

Target

See all BTLA Antibodies
BTLA (B and T Lymphocyte Associated (BTLA))

Reactivity

  • 80
  • 31
  • 2
  • 2
  • 2
  • 1
Mouse

Host

  • 45
  • 36
  • 9
  • 3
  • 1
  • 1
  • 1
Rat

Clonality

  • 51
  • 43
  • 2
Monoclonal

Conjugate

  • 54
  • 5
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BTLA antibody is conjugated to Biotin

Application

  • 48
  • 48
  • 30
  • 13
  • 13
  • 12
  • 11
  • 10
  • 7
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
Flow Cytometry (FACS)

Clone

PK18-6
  • Isotype

    IgG1, kappa
  • Application Notes

    For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 10^6 cells in 100 µL volume or 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

    Comment

    Matching Isotype Control: Biotin Rat IgG1, κ Isotype Control (ABIN7469820)

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    PBS with 0.05 % Proclin300, 1 % BSA

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 2~8°C. Do not freeze.
  • Target

    BTLA (B and T Lymphocyte Associated (BTLA))

    Alternative Name

    CD272

    Background

    B- and T-lymphocyte attenuator,Btla,B- and T-lymphocyte-associated protein,CD272,Btla,CD272, also known as B and T lymphocyte attenuator (BTLA), is an Ig superfamily co-inhitory receptor with structural similarity to programmed cell death 1 (PD-1) and CTLA-4. BTLA is expressed on B cells, T cells, macrophages, dendritic cells, NKT cells, and NK cells. Engagement of BTLA by its ligand herpes virus entry mediator (HVEM) is critical for negatively regulating immune response. The absence of BTLA with HVEM inhibitory interactions leads to increased experimental autoimmune encephalomyelitis severity, enhanced rejection of partially mismatched allografts, an increased CD8+ memory T cell population, increased severity of colitis, and reduced effectiveness of T regulatory cells. BTLA plays an important role in the induction of peripheral tolerance of both CD4+ and CD8+ T cells in vivo. Tolerant T cells have significantly higher expression of BTLA compared with effectors and naive T cells. BTLA may cooperate with CTLA-4 and PD-1 to control T cell tolerance and autoimmunity. It was reported that BTLA may regulate T cell function by binding to B7-H4, but further studies are needed to confirm. The existence of three distinct BTLA alleles has been reported.

    Gene ID

    208154

    UniProt

    Q7TSA3

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!